Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Scandinavian Clinical Nutrition has entered into an exclusive distribution agreement for Coldizin with Negma Laboratories, an integrated pharmaceutical group in France.
Subscribe to our email newsletter
Coldizin will be sold under private label as a food supplement, and marketed throughout the country through Negma’s sales and marketing organization. The launch is planned for the fourth quarter of 2008.
Danilo Copiz, Scandinavian Clinical Nutrition’s (SCN’s) vice president of sales, said: “This is a great opportunity for Coldizin. The product has strong scientific documentation and patent protection, and Negma’s experience of selling high-quality products and their nation-wide distribution makes them an ideal distribution partner.”